Published in Cardiovascular Ultrasound in January 2026, the study evaluated 194 patients with severe left ventricular systolic dysfunction who were referred for evaluation of advanced therapeutic options, including left ventricular assist device (LVAD) implantation or heart transplantation. The findings indicate that left atrial reservoir strain (LASr) and left atrial minimum volume index (LAVImin) are significantly associated with adverse clinical outcomes and reduced exercise capacity, offering potential tools for refined risk stratification in this high-risk population.
The study was designed to address a gap in understanding how left atrial remodeling influences prognosis in advanced heart failure (AHF). While left atrial dysfunction is recognized as a contributor to heart failure outcomes, its specific relevance in patients with the most severe disease, those with left ventricular ejection fractions of 25% or less, had not been sufficiently defined. The research team aimed to determine whether echocardiographic left atrial indices could predict a composite endpoint of all-cause death, LVAD implantation, or heart transplantation, and to explore their relationship with cardiopulmonary exercise testing (CPET) parameters that reflect functional capacity.
The cohort consisted of 194 patients admitted to the heart transplantation outpatient clinic between 2021 and 2023. These individuals met the 2021 European Society of Cardiology guidelines for advanced heart failure, characterized by persistent severe symptoms (NYHA class III–IV) and objective evidence of cardiac dysfunction despite optimal medical therapy. Patients were excluded if they had an ejection fraction greater than 25%, severe pulmonary disease, contraindications to exercise testing or catheterization, or prior valvular surgery. All participants underwent a comprehensive baseline evaluation within a 48 to 72-hour window, including transthoracic echocardiography, right heart catheterization, and maximal cardiopulmonary exercise testing on a treadmill.
Echocardiographic imaging was performed by a single experienced cardiologist using a Philips EPIQ CVx system. The study utilized two-dimensional speckle-tracking echocardiography to calculate left atrial strain, in accordance with ASE/EACVI consensus recommendations. Several novel and established indices were assessed, including LASr, LAVImin, left atrial ejection fraction (LAEF), and left atrial expansion index (LAEI). The LASr was derived from the apical four-chamber view, while volumetric indices were calculated by dividing left atrial volumes by body surface area. In patients with atrial fibrillation, 3D volumetric measurements were averaged over five consecutive beats to ensure accuracy.
Patients were stratified into two groups based on their LASr values, with a median-based cutoff of 8.35% used for dichotomization. The lower LASr group exhibited more advanced atrial remodeling, higher filling pressures, and worse ventricular function compared to the higher LASr group. Specifically, the lower LASr group had a higher prevalence of atrial fibrillation (22.7% vs. 9.3%) and more frequent implantable cardioverter-defibrillator (ICD) use. Invasive hemodynamic data revealed that patients with impaired LASr had higher left ventricular end-diastolic pressures and pulmonary vascular resistance, alongside lower cardiac output and cardiac index, indicating more severe biventricular hemodynamic compromise.
During a median follow-up of 461 days, adverse outcomes occurred significantly more frequently in the lower LASr group. The composite endpoint of all-cause death, LVAD implantation, or heart transplantation was observed in 35.1% of patients with low LASr compared to 14.4% in those with higher LASr (p = 0.002). LVAD implantation was particularly more common in the lower LASr group (18.6% vs. 4.1%, p = 0.003). Multivariable Cox regression analyses, adjusted for established prognostic variables such as age, sex, body mass index, and comorbidities, confirmed that both LASr and LAVImin independently predicted the composite endpoint. LASr was associated with a hazard ratio of 0.57 (95% CI 0.36–0.92), while LAVImin was associated with a hazard ratio of 1.64 (95% CI 1.16–2.34).
The study also demonstrated that these left atrial indices provided incremental prognostic value beyond conventional clinical and echocardiographic parameters. The baseline clinical model had a Harrell’s C-index of 0.753, which increased to 0.786 with the addition of LASr and to 0.781 with the addition of LAVImin. Restricted cubic spline analyses revealed non-linear associations, with progressively increasing risk at lower LASr values and higher LAVImin levels. These results suggest that functional assessment of the left atrium offers complementary information that is not captured by left ventricular ejection fraction alone, which often loses discriminative power in patients with severe systolic dysfunction.
Regarding functional relevance, the researchers examined correlations between left atrial mechanics and exercise performance. LASr, LAEF, and LAEI showed positive associations with peak oxygen uptake (peak VOâ‚‚), with all p-values less than 0.001. Patients in the lower LASr group demonstrated markedly impaired functional capacity, including shorter exercise duration, lower peak workload, and reduced peak VOâ‚‚ (12.5 vs. 14.7 mL/kg/min). The lower LASr group also exhibited greater ventilatory inefficiency, indicated by a steeper VE/VCOâ‚‚ slope. These findings support a link between impaired atrial reservoir and booster pump function and reduced aerobic capacity in patients with advanced heart failure.
The authors noted that while left atrial dysfunction may contribute to exercise intolerance through impaired hemodynamic reserve, its relative impact on peak VOâ‚‚ may be attenuated by dominant peripheral limitations. In advanced heart failure, factors such as impaired skeletal muscle perfusion, reduced capillary density, and mitochondrial dysfunction play a major role in limiting aerobic capacity. Therefore, the modest strength of the associations observed between left atrial functional indices and exercise capacity should be interpreted in the context of these multiple central and peripheral determinants of functional performance.
The study has several limitations that the authors acknowledge. Its retrospective and single-center design may introduce selection bias and limit the generalizability of the findings, as the population comprised patients referred for advanced therapies. The applicability of the results to patients with less advanced stages of heart failure should be interpreted with caution. Additionally, strain and volumetric parameters are dependent on image quality and vendor-specific software, and cardiac output was estimated using the indirect Fick method, which is subject to measurement variability. Therapeutic strategies were not strictly standardized due to the retrospective nature of the study, reflecting real-world management of advanced heart failure.
The researchers concluded that LASr and LAVImin are independently associated with adverse clinical outcomes and reduced exercise tolerance in patients with advanced heart failure. Incorporation of these left atrial functional assessments into routine echocardiographic evaluation may help improve risk stratification and support clinical decision-making in this high-risk population. By providing incremental prognostic and functional information, these indices could serve as valuable tools to guide timely referral for advanced therapies such as LVAD implantation or heart transplantation.
This study contributes to the growing body of evidence highlighting the prognostic importance of atrial function in heart failure. By confirming the relevance of LASr and LAVImin in a high-risk cohort, the findings extend previous observations from less severe populations. The results underscore the need for larger, prospective, and multicenter cohorts to validate these associations in broader clinical settings and to further define the role of left atrial mechanics in the management of advanced heart failure.
Subject of Research: Prognostic and functional value of left atrial indices in advanced heart failure
Article Title: Prognostic and functional value of left atrial indices in advanced heart failure
Article References: Karaçam, M., Kültürsay, B., Kaya, A., Tanyeri, S., Mutlu, D., Efe, S. Ç., Bulus, Ç., Halil, G. S., Eminoğlu, H., Kırali, K., & Acar, R. D. (2026). Prognostic and functional value of left atrial indices in advanced heart failure. Cardiovascular Ultrasound, 24(1), Article 5. https://doi.org/10.1186/s12947-026-00366-6
Image Credits: AI Generated
DOI: 10.1186/s12947-026-00366-6
Keywords: Prognostic, functional, value, left, atrial, indices, advanced, heart, failure, scientific research
News Source: Ophelia Keating. (November 10, 2026). Left Atrial Metrics Predict Outcomes in Advanced Heart Failure. Scienmag.



